TW200617162A - Surface display vector of sars virus antigen and microorganisms transformed thereby - Google Patents
Surface display vector of sars virus antigen and microorganisms transformed therebyInfo
- Publication number
- TW200617162A TW200617162A TW093136838A TW93136838A TW200617162A TW 200617162 A TW200617162 A TW 200617162A TW 093136838 A TW093136838 A TW 093136838A TW 93136838 A TW93136838 A TW 93136838A TW 200617162 A TW200617162 A TW 200617162A
- Authority
- TW
- Taiwan
- Prior art keywords
- sars
- surface display
- virus antigen
- display vector
- sars virus
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a surface expression vector of SARS coronavirus antigen containing a gene encoding an antigen of SARS inducing coronavirus and any one or two or more of genes pgsB, pgsC and pgsA encoding poly-gamma-glutamic acid synthase complex, a microorganism transformed by the surface expression vector, and a SARS vaccine comprising the microorganism. According to the present invention, it is possible to economically produce a vaccine for prevention and treatment of SARS using a recombinant strain expressing an SARS coronavirus antigen on their surface.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW93136838A TWI297359B (en) | 2004-11-30 | 2004-11-30 | Surface display vector of sars virus antigen and microorganisms transfomred thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW93136838A TWI297359B (en) | 2004-11-30 | 2004-11-30 | Surface display vector of sars virus antigen and microorganisms transfomred thereby |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200617162A true TW200617162A (en) | 2006-06-01 |
TWI297359B TWI297359B (en) | 2008-06-01 |
Family
ID=45069064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW93136838A TWI297359B (en) | 2004-11-30 | 2004-11-30 | Surface display vector of sars virus antigen and microorganisms transfomred thereby |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI297359B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112430611A (en) * | 2020-11-30 | 2021-03-02 | 华南理工大学 | Optimized zearalenone degrading enzyme ZHD-P encoding gene, recombinant thallus, surface display system and application |
-
2004
- 2004-11-30 TW TW93136838A patent/TWI297359B/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112430611A (en) * | 2020-11-30 | 2021-03-02 | 华南理工大学 | Optimized zearalenone degrading enzyme ZHD-P encoding gene, recombinant thallus, surface display system and application |
Also Published As
Publication number | Publication date |
---|---|
TWI297359B (en) | 2008-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100469936B1 (en) | Cell Surface Expression Vector of SARS Virus Antigen and Microorganisms Transformed Thereby | |
CY1106334T1 (en) | OPTIMIZED PAMMILA VIRUS CODING SEQUENCES | |
MY140829A (en) | Chimeric adenoviruses for use in cancer treatment | |
MX2010003371A (en) | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof. | |
BRPI0921758A2 (en) | bifidobacterium longum | |
WO2005059093A3 (en) | P ef-tu expression units | |
MX2018008135A (en) | Influenza nucleic acid molecules and vaccines made therefrom. | |
WO2010122367A3 (en) | Meganuclease variants cleaving the genomic insertion of a virus and uses thereof | |
WO2007062936A3 (en) | Dna binding site of a transcriptional activator useful in gene expression | |
MA30581B1 (en) | RECOMBINANT VIRAL VACCINE | |
SG156690A1 (en) | Mammalian genes involved in infection | |
NZ597601A (en) | Treatment and prevention of influenza | |
MX2007009628A (en) | Replication-deficient rna viruses as vaccines. | |
WO2020127532A3 (en) | Rna encoding a protein | |
WO2008133137A1 (en) | Vector for gene therapy | |
BRPI0518109A (en) | bacterial strain, nucleocapsid, vaccine preparation, method for creating a recombinant bacterium, mutant bacterium, fluorinated rna sequences and electroporation medium | |
TNSN07090A1 (en) | Novel laccase enzyme and use thereof | |
WO2012135600A3 (en) | Gall wasp control agents | |
UA90098C2 (en) | Promoter of vaccinia virus | |
TW200617162A (en) | Surface display vector of sars virus antigen and microorganisms transformed thereby | |
ATE464385T1 (en) | N-ACETYL-(R,S)-B-AMINO ACID ACYLASE GENES | |
UA93658C2 (en) | Cell surface glycoprotein | |
WO2001072977A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
ATE338826T1 (en) | RECOMBINANT VIRAL VECTORS FOR TETRACYCLINE-REGULABLE GENE EXPRESSION | |
GB201018125D0 (en) | Peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |